|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
28.000 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 392,322 | 15.469% | 752,836 | 585,883 | 464,675 | 358,428 |
| Cost of Sales | (145,554) | 4.404% | (314,766) | (253,397) | (188,930) | (124,013) |
| Gross Profit | 246,768 | 23.168% | 438,070 | 332,486 | 275,745 | 234,415 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 652 | 35.551% | -- | -- | (567) | 44 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 110,749 | 25.258% | 175,128 | 144,468 | 155,691 | 137,085 | |
| Taxation | (11,571) | 46.246% | (21,900) | (10,635) | (15,246) | (20,568) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,360 | -- | 3,229 | (2,120) | 2,515 | 4,837 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 100,538 | 24.889% | 156,457 | 131,713 | 142,960 | 121,354 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (3,216) | -36.606% | (8,637) | (12,590) | (13,892) | (24,003) |
| Depreciation & Amortisation | 42,134 | 101.492% | 47,554 | 37,077 | 30,216 | 21,964 |
| Directors' Emoluments | -- | -- | 9,332 | 6,916 | 2,425 | 1,973 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 58.000 | 20.833% | 92.000 | 79.000 | 86.000 | 73.000 |
| DPS (cts) | 0.000 | -- | 27.000 | 24.000 | 26.000 | 28.500 |
| Dividend Payout Ratio (%) | -- | -- | 29.348% | 30.380% | 30.233% | 39.041% |
| Cash flow per share ($) | -- | -- | 1.074 | 1.087 | 0.438 | 0.577 |
| NBV per share ($) | 9.538 | -- | 9.645 | 9.000 | 8.406 | 7.865 |
| Remarks: | Real time quote last updated: 11/11/2024 10:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 100,538,000 |
| %Change | 24.889% |
| EPS / (LPS) | RMB 0.580 |
| NBV Per Share (¥) | RMB 9.538 |